| Nov 16 |
Is Aquestive Therapeutics (AQST) the Best Multibagger Stock to Buy Heading into 2025?
|
| Nov 6 |
Aquestive Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Nov 6 |
Aquestive Therapeutics Inc (AQST) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ...
|
| Nov 5 |
Aquestive Therapeutics, Inc. (AQST) Q3 2024 Earnings Call Transcript
|
| Nov 5 |
Aquestive: Rare Opportunity With Dual Platform Strategy
|
| Nov 5 |
Aquestive Therapeutics, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 5 |
Aquestive Therapeutics (AQST) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
|
| Nov 4 |
Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 4 |
Aquestive Therapeutics: Q3 Earnings Snapshot
|
| Nov 4 |
Aquestive Therapeutics GAAP EPS of -$0.13 in-line, revenue of $13.54M beats by $0.86M
|
